Renk's Share Price Keeps Sliding Even as JPMorgan Paints a Bullish Takeover Picture

Renk shares fall 7.8% weekly despite JPMorgan's €75 target, as weak Q2 earnings and takeover speculation clash with market skepticism.

The gap between what analysts say about Renk Group and what the market actually does with the stock has rarely been wider. JPMorgan's David Perry reaffirmed an "Overweight" rating with a €75 price target this week, framing the Munich-based tank gearbox maker as a prime consolidation candidate in a European defence sector bracing for a wave of dealmaking. The market's response? A fleeting intraday pop of nearly four percent on Wednesday morning that fizzled into a barely positive close, followed by renewed selling.

By Friday, the shares were changing hands at €47.67, down 1.1 percent on the day and 7.8 percent lower on the week. That extends a bruising stretch that has seen the stock shed roughly nine percent of its value relative to its 200-day moving average of €52.36 — a technical signal that the medium-term trend has already turned. The 52-week high of €90.20, reached in early October, now looks like a distant memory, with the shares down 12 percent year-to-date and 18 percent over the past twelve months.

The tension is hard to miss: a blue-chip bank endorsing the stock at levels implying roughly 57 percent upside, while the tape keeps drifting lower. The explanation lies in the collision between two competing narratives — the enduring allure of a potential takeover and the sobering reality of the company's most recent financial disclosures.

The Numbers Behind the Skepticism

Renk's second-quarter results, published earlier this year, gave investors pause. Earnings per share came in at €0.15, half the €0.30 recorded in the same period a year earlier, while revenue of €353.59 million barely nudged past the prior-year figure of €347.53 million. The market's reaction was swift and unforgiving, with analysts like wallstreetONLINE's Maximilian Berger warning that the takeover fantasy could prove a dangerous trap if doubts about the defence boom begin to overshadow it.

The full-year picture, however, tells a more nuanced story. The half-year numbers released in August showed revenue climbing to €637.2 million, with adjusted EBIT of €98.2 million — a gain of just over ten percent year-on-year. The adjusted EBIT margin improved from 14.4 to 15.4 percent, and order intake surged nearly 30 percent to just under €1.2 billion. Management used those figures to reaffirm guidance calling for revenue above €1.5 billion and adjusted EBIT in the range of €255 million to €285 million.

JPMorgan's decision to raise its earnings estimates rests partly on that upgraded outlook and partly on a strategic acquisition still in the works. Renk signed a deal on July 3, 2026 to buy David Brown Defence, a British specialist in gearboxes for naval and land defence applications, bringing with it a project pipeline worth more than £700 million spanning 2026 through 2030. The transaction has yet to close, but the order book already stands at a hefty €7.4 billion.

A Market That Refuses to Be Convinced

The central question hanging over the stock is whether analysts' consensus forecast of €1.72 earnings per share for 2026 remains achievable. That figure presupposes a significant acceleration in profitability during the second half — a demanding assumption given the weak second quarter. The November 5 third-quarter report will provide the first real test of whether that momentum is materialising.

Bulls point out that the stock remains in positive territory on a one-month basis despite the recent slide, and that a credible takeover bid or strategic stake could quickly send the shares back toward the €90 mark reached last October. The political tailwinds for European defence spending remain intact, which should underpin demand for military drivetrain technology.

Bears counter that the recent price action is not noise but signal. The stock sits 8.6 percent below its 200-day average, a level that suggests the medium-term trend has already broken. If the weak second quarter proves to be the start of a structural slowdown rather than a one-off blip, the €1.72 consensus estimate becomes increasingly difficult to defend — and the takeover narrative loses its anchor.

The Technical Line in the Sand

For now, the 50-day moving average of approximately €46.67 serves as the key support level. As long as the shares hold above that mark, the near-term downside pressure remains contained and a stabilisation is possible. A sustained break below it, however, would likely shift investor focus decisively away from M&A speculation and toward operational weakness, raising the risk of further declines toward the year's low.

Until November 5 arrives, the stock seems destined to oscillate between takeover hope and earnings reality. JPMorgan's €75 target implies substantial upside from current levels, but the market's refusal to embrace that view suggests investors are waiting for proof — in the form of hard numbers — before they buy into the optimism. The order book is strong, the strategic logic for consolidation is clear, and the defence sector enjoys political favour. Whether that translates into a higher share price is a question only the third-quarter results can begin to answer.